同结晶:一种新的技术,即兴改进API的药物特性
1Department of Pharmaceutical Sciences, Maharshi Dayanand University, Rohtak, India.
Current drug targets
|July 27, 2023
概括
晶体工程,特别是联合结晶,提供了一种可行的方法来提高药物的溶解性和生物可用性. 这种技术利用超分子合成子来修改性能,解决活性药物成分 (API) 的不良溶解概况.
科学领域:
- 制药科学 制药科学
- 材料科学 材料科学 材料科学
- 化学工程是化学工程的重要组成部分.
背景情况:
- 活性药物成分 (API) 的水溶性较差显著限制了药物的溶解和生物可用性.
- 传统的方法,如固体分散和纳米技术,用于提高溶解度.
- 晶体工程为克服可溶性挑战提供了一个有希望的替代方案.
研究的目的:
- 审查使用晶体工程提高溶解度的最新进展.
- 探索晶体工程在修改药物的物理化学性质的应用.
主要方法:
- 关于晶体工程发展的综合文献调查.
- 专注于共同结晶作为一个关键的晶体工程技术.
主要成果:
- 同结晶涉及API和coformer相互作用形成超分子合成子.
- 超分子合成子使性能调节和跨不同系统的可转移性成为可能.
- 广泛的食品和药品等级的配体促进了所需的物理化学性质的修改.
结论:
- 结晶工程,特别是联合结晶,对于提高药物的溶解性和生物可用性是有效的.
- 该审查涵盖了晶体工程的选,制备,表征和制药应用.
- 还讨论了扩大规模和监管准则的考虑因素.
相关概念视频
Crystal Growth: Principles of Crystallization
2.1K
Crystallization is a phase transformation process in which crystals are precipitated from a supersaturated solution or formed from other sources. During crystallization, atoms or molecules arrange themselves into a well-defined, rigid crystal lattice to minimize energy.
Initiating crystallization involves manipulating the concentration of the solute and the temperature of the solution. Since crystal growth occurs when the ratio of concentration and solubility of the solute in the solvent...
Initiating crystallization involves manipulating the concentration of the solute and the temperature of the solution. Since crystal growth occurs when the ratio of concentration and solubility of the solute in the solvent...
2.1K
Recrystallization: Solid–Solution Equilibria
1.1K
Recrystallization is a purification technique used to separate impurities from solid compounds. In this technique, no chemical reactions occur. Instead, it exploits physical properties only, specifically, the solubility differences between the desired compound and impurities, either at a single temperature or at different temperatures, and under other selected conditions. The solid-solution equilibrium (solubility equilibrium) of each component in the solution represents a binary phase...
1.1K
Factors Affecting Dissolution: Polymorphism, Amorphism and Pseudopolymorphism
338
Polymorphism refers to the existence of a drug substance in multiple crystalline forms, known as polymorphs. Recently, this term has been expanded to include solvates (forms containing a solvent), amorphous forms (non-crystalline forms), and desolvated solvates (forms from which the solvent has been removed).
Some polymorphic crystals possess lower aqueous solubility than their amorphous counterparts, leading to incomplete absorption. For instance, the oral suspension of Chloramphenicol, which...
Some polymorphic crystals possess lower aqueous solubility than their amorphous counterparts, leading to incomplete absorption. For instance, the oral suspension of Chloramphenicol, which...
338
Factors Influencing Drug Absorption: Pharmaceutical Parameters
154
Solid dosage forms such as tablets and capsules undergo rigorous manufacturing processes to ensure stability and effectiveness. Their dissolution and absorption properties are influenced significantly by the choice of excipients (inactive ingredients that serve various roles in the formulation), and the methodology applied during production. The manufacturing parameters, such as compression force and granulation techniques, significantly affect dissolution rates. Elevated compression forces...
154
Precipitation Processes
488
The experimental conditions in a gravimetric analysis should be optimized to maximize the particle size and purity of the obtained precipitate. Ideally, the concentration of the precipitating reagent should be low with effective stirring to maintain low relative supersaturation for the growth of large crystals. In homogeneous precipitation, the precipitant is slowly generated by a chemical reaction in the solution to avoid local reagent excesses. For example, urea decomposes gradually to...
488


